LIGAND PHARMACEUTICALS

Company

LIGAND PHARMACEUTICALS INC

Filed

February 12, 2003

Accession Number

0001162663-03-000006

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →